HCPCS Level II J9245: Melphalan Hydrochloride Injection, 50 mg
HCPCS Level II code J9245 denotes an injection of melphalan hydrochloride, not otherwise specified, 50 mg, typically billed for systemic chemotherapy administered via intravenous infusion or injection in an oncology clinic, hospital outpatient department, or infusion center; this descriptor identifies the drug, unit of measure (50 mg), and the clinical context for oncology drug administration claims coding.
For related coverage guidance, see recent payer policy updates: Bendamustine Products Coverage Criteria, T-Cell Lymphoma Agents: Beleodaq, Istodax, Lymphir, Poteligeo, and Romidepsin, Brentuximab Vedotin (Adcetris®) Coverage Criteria.
Customize your policy alerts
Sign up for hcpcs J9245 policy alerts
Get alerted when payer policies referencing J9245 are released or updated.
Monitor payer policy activity